Objectively Diagnose and Monitor Treatment of Light Sensitivity
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- Randy Kardon
- Study ID
- NCT03694626
- Status
- Recruiting
Conditions
- Migraine
- Photophobia
- Traumatic Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Pupillography — DEVICEA hand-held pupillometer/electroretinogram device (RETeval, LKC) will be held in front of the subject's eye, but will not touch the eye. The device will provide a brief, a series of brief light stimuli and then record the pupil response and the elicited electrical response from the retina from a surface skin patch (electrode) placed below each eye, from the light as a measure of whether the inherent sensitivity of the eye in the retina is normal. The investigators will repeat this in the left eye. The visible light stimulus is safe and is given at an intensity experienced in normal daily light exposures. The test takes about 2 minutes per eye.
- Ocular Coherence Tomography (OCT) — DEVICEThe thickness of the optic nerve and macula will also be measured inside of the eye using a special camera that forms an image of the layers of the retina without pupil dilation. The imaging is harmless and measures the structural health of the optic nerve and retinal layers. This test takes 5-10 minutes per eye.
- Wrist-watch sensor device — DEVICEA wrist-watch sensor device (E4, Empatica) will be place on each wrist to measure skin conductance, heart rate, skin temperature and arm movement during testing. These wrist-watch devices are being used to monitor changes in sympathetic nerve activity to light intensity, (the sympathetic nerves supply the blood vessels to the skin and heart).
- Videography — DEVICEThe subject will sit comfortably in front of miniature combination infrared/visible light video cameras and infrared diode light source located within 1 meter to provide video recording of the face during testing with light and during darkness, described next. After the 10 minutes of dark-adapting, the subject will put his/her chin on a chin rest in front of the video cameras and a light emitting diode (LED) array give diffuse red, blue, and white stimuli over a range of intensities. None of the stimuli are as bright as a flash from a camera and are in the range of intensities normally experienced during daily activities. At the end of the test the investigators will add filters over the glasses: orange (blue-blocking) filters and neutral density filters. Subjects will grade independently, both the brightness and discomfort they feel from each light stimulus intensity.
- Electrophysiology — DEVICENext, electrodes will be placed above, below and to the side of the test eye to record the electromyogram (EMG) for measuring eyelid opening and blink rate.
Study Details
The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.
Key Dates
- Start date
- Jul 11, 2019
- Status verified
- May 2025
- Primary completion
- Jan 1, 2028
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Active Comparator: Healthy Control subjects
- Active Comparator: TBI Patients without photosensitivity
- Active Comparator: Migraine patients without photosensitivity
- Active Comparator: Migraine patients with photosensitivity
- Active Comparator: TBI patients with photosensitivity
Primary Outcome Measure
Correlation of facial responses to light sensitivity [ Time Frame: 1 Day ]
Central Contacts
- Julie Nellis, BSN319-356-2780
- Jan Full, BSN3193562780
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Iowa Health Care | Iowa City | Iowa | 52242 | - |
Find similar trials in Iowa City, IA
By condition
By specialty
By research site
Related Studies
- Hyperbaric Oxygen Brain Injury Treatment TrialPHASE2 · Recruiting · Gaylan Rockswold · San Diego, California
- The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)Recruiting · University of Michigan · San Diego, California
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)PHASE3 · Enrolling By Invitation · AbbVie · Huntsville, Alabama